Clinical trial
A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia
NCT00176566 · University of Medicine and Dentistry of New Jersey, Other · Terminated
Key facts
| NCT number | NCT00176566 |
|---|---|
| Title | A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia |
| Official title | A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia |
| Lead sponsor | University of Medicine and Dentistry of New Jersey, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Oral Leukoplakia |
| Intervention type | Drug |
| Interventions | Lozenge Intake |
| Enrollment | 8 |
| Start date | Sep 1, 2003 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 11, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: